Last reviewed · How we verify
NCT03160053
Improving Keloids Using Targeted Ultraviolet-B Irradiation
NA trial testing NB-UVB in Keloid in 2 participants. Completed in 15 June 2018.
20 November 2015
Quick facts
| Lead sponsor | Johns Hopkins University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 2 |
| Start date | 23 June 2015 |
| Primary completion | 20 November 2015 |
| Estimated completion | 15 June 2018 |
Drugs / interventions tested
- NB-UVB — full drug profile →
Conditions studied
- Keloid — all drugs for Keloid →
Sponsor
Johns Hopkins University
Who can join
18 and older, any sex, with Keloid. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Treatment of keloids with targeted Ultraviolet-Beta (UVB) radiation will improve the clinical appearance and induration of lesions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Current State of Clinical Trials for Keloid Management: An Analysis of Trials Registered on ClinicalTrials.gov.
Park S, Li D, Guo L, Xu X. · · 2026 · PMID 42077711 · DOI 10.7759/cureus.106243
Verify or expand the search:
- PubMed search for NCT03160053
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NB-UVB
Trials testing the same drug.
- NCT06593197 — Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients · Phase 4 · enrolling by invitation
- NCT06712238 — Evaluation The Effect of NB-UVB and Methotrexate on The Level of Serum Gelsolin in Psoriatic Patients · NA · recruiting
- NCT04811326 — Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation · Phase 4 · unknown
- NCT05647187 — Effect Narrow-Band UVB Radiations · NA · completed
- NCT04071106 — Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial · Phase 2, PHASE3 · unknown
Other recruiting trials for Keloid
Currently open trials in the same condition.
- NCT06431360 — Effect of Strontium-90 Brachytherapy Combined With Hyperthermia in the Treatment of Keloid · NA · recruiting
- NCT06138964 — Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars · Phase 2 · recruiting
Other Johns Hopkins University trials
Trials by the same sponsor.
- NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
- NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
- NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
- NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
- NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03160053 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
- Last refreshed: 19 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03160053.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing